Skip to main content
. 2020 Sep 2;8:519. doi: 10.3389/fped.2020.00519

Figure 2.

Figure 2

Duration of long-term azithromycin courses prescribed by respondents for children with chronic suppurative lung disease and bronchiectasis. Note: category numbers are not mutually exclusive. Other responses included: Azithromycin prescribed only for cystic fibrosis patients; and duration determined by patient's age and previous response following cessation of azithromycin (response to Q16).